Differential expression analysis between the sequencing data from the human ER+ BC cell line MCF-7 (ET sensitive) and LCC9 (tamoxifen and fulvestrant resistant) revealed four CRGs that were significantly different from the 13 CRGs (Fig. 4A). Here, ESR1 is linked to breast cancer.